NCT07280312
Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions
Recruiting
NAAges 18+InterventionalDiagnosticMayo ClinicInvestigator-initiated
~40 participants
Updated 2026-02-03 on ClinicalTrials.gov
What's tested:Transvaginal UltrasoundUltrasound Microvessel Imaging
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in O-RADS score
Measured over Baseline
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- Shigao D. Chen, PhD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Female patients aged ≥ 18 years
Scheduled for surgery for ovarian or adnexal lesions
Exclusion
Prior surgical removal of ovarian or adnexal lesions
Undergoing neoadjuvant chemotherapy or targeted systemic therapy
Vulnerable populations, including prisoners, adults lacking capacity to consent, and pregnant women (our study coordinator will ask participants if they are pregnant; if uncertain, a urine pregnancy test will be offered at no cost).
What this trial measures
- Change in O-RADS scoreBaseline
Ovarian-Adnexal Reporting and Data System (O-RADS) scores will be initially based on B-mode and Doppler imaging (standard of care) obtained prior to surgical treatment. Radiologists will then review ultrasound microvessel imaging (UMI) images and may choose to revise the score. Accuracy of score adjustments will be assessed using final pathology results from the participant's medical record.